These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
412 related articles for article (PubMed ID: 21393040)
1. Combined Hurler and Sanfilippo syndrome in a sibling pair. Sun A; Hopwood JJ; Thompson J; Cederbaum SD Mol Genet Metab; 2011 Jun; 103(2):135-7. PubMed ID: 21393040 [TBL] [Abstract][Full Text] [Related]
2. [Hurler syndrome: early diagnosis and treatment]. Leroux S; Muller JB; Boutaric E; Busnel A; Lemouel F; Andro-Garçon M; Neven B; Valayannopoulos V; Vinceslas C Arch Pediatr; 2014 May; 21(5):501-6. PubMed ID: 24698225 [TBL] [Abstract][Full Text] [Related]
3. Mucopolysaccharidosis type I. Wraith JE; Jones S Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():102-6. PubMed ID: 25345091 [TBL] [Abstract][Full Text] [Related]
4. Intrafamilial variability in Hurler syndrome and Sanfilippo syndrome type A: implications for evaluation of new therapies. McDowell GA; Cowan TM; Blitzer MG; Greene CL Am J Med Genet; 1993 Nov; 47(7):1092-5. PubMed ID: 7507293 [TBL] [Abstract][Full Text] [Related]
5. Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications. Yogalingam G; Hopwood JJ Hum Mutat; 2001 Oct; 18(4):264-81. PubMed ID: 11668611 [TBL] [Abstract][Full Text] [Related]
6. The mutation p.Ser298Pro in the sulphamidase gene (SGSH) is associated with a slowly progressive clinical phenotype in mucopolysaccharidosis type IIIA (Sanfilippo A syndrome). Meyer A; Kossow K; Gal A; Steglich C; Mühlhausen C; Ullrich K; Braulke T; Muschol N Hum Mutat; 2008 May; 29(5):770. PubMed ID: 18407553 [TBL] [Abstract][Full Text] [Related]
7. [Postnatal and prenatal diagnosis of mucopolysaccharidosis type III (Sanfilippo syndrome)]. Zhang WM; Shi HP; Meng Y; Li BT; Qiu ZQ; Liu JT Zhonghua Er Ke Za Zhi; 2008 Jun; 46(6):407-10. PubMed ID: 19099774 [TBL] [Abstract][Full Text] [Related]
8. Sanfilippo syndrome in Turkey: Identification of novel mutations in subtypes A and B. Emre S; Terzioglu M; Tokatli A; Coskun T; Ozalp I; Weber B; Hopwood JJ Hum Mutat; 2002 Feb; 19(2):184-5. PubMed ID: 11793481 [TBL] [Abstract][Full Text] [Related]
9. Cloning of the sulphamidase gene and identification of mutations in Sanfilippo A syndrome. Scott HS; Blanch L; Guo XH; Freeman C; Orsborn A; Baker E; Sutherland GR; Morris CP; Hopwood JJ Nat Genet; 1995 Dec; 11(4):465-7. PubMed ID: 7493035 [TBL] [Abstract][Full Text] [Related]
11. Does early use of enzyme replacement therapy alter the natural history of mucopolysaccharidosis I? Experience in three siblings. Laraway S; Breen C; Mercer J; Jones S; Wraith JE Mol Genet Metab; 2013 Jul; 109(3):315-6. PubMed ID: 23721889 [TBL] [Abstract][Full Text] [Related]
12. Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients. Oussoren E; Keulemans J; van Diggelen OP; Oemardien LF; Timmermans RG; van der Ploeg AT; Ruijter GJ Mol Genet Metab; 2013 Aug; 109(4):377-81. PubMed ID: 23786846 [TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of 20 novel pathogenic variants in 60 unrelated Indian patients with mucopolysaccharidoses type I and type II. Uttarilli A; Ranganath P; Matta D; Md Nurul Jain J; Prasad K; Babu AS; Girisha KM; Verma IC; Phadke SR; Mandal K; Puri RD; Aggarwal S; Danda S; Sankar VH; Kapoor S; Bhat M; Gowrishankar K; Hasan AQ; Nair M; Nampoothiri S; Dalal A Clin Genet; 2016 Dec; 90(6):496-508. PubMed ID: 27146977 [TBL] [Abstract][Full Text] [Related]
14. 18-year follow-up of enzyme-replacement therapy in two siblings with attenuated mucopolysaccharidosis I. Pjetraj D; Santoro L; Sgattoni C; Padella L; Zampini L; Monachesi C; Gabrielli O; Catassi C Am J Med Genet A; 2023 Feb; 191(2):564-569. PubMed ID: 36333985 [TBL] [Abstract][Full Text] [Related]
15. Diagnosing lysosomal storage disorders: mucopolysaccharidosis type I. Johnson BA; Dajnoki A; Bodamer OA Curr Protoc Hum Genet; 2015 Jan; 84():17.17.1-17.17.8. PubMed ID: 25599668 [TBL] [Abstract][Full Text] [Related]
16. Enzyme-replacement therapy in a 5-month-old boy with attenuated presymptomatic MPS I: 5-year follow-up. Gabrielli O; Clarke LA; Bruni S; Coppa GV Pediatrics; 2010 Jan; 125(1):e183-7. PubMed ID: 20026495 [TBL] [Abstract][Full Text] [Related]
17. Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications. Scott HS; Bunge S; Gal A; Clarke LA; Morris CP; Hopwood JJ Hum Mutat; 1995; 6(4):288-302. PubMed ID: 8680403 [TBL] [Abstract][Full Text] [Related]
18. Four novel mutations underlying mild or intermediate forms of alpha-L-iduronidase deficiency (MPS IS and MPS IH/S). Tieu PT; Bach G; Matynia A; Hwang M; Neufeld EF Hum Mutat; 1995; 6(1):55-9. PubMed ID: 7550232 [TBL] [Abstract][Full Text] [Related]
19. Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy. Yogalingam G; Guo XH; Muller VJ; Brooks DA; Clements PR; Kakkis ED; Hopwood JJ Hum Mutat; 2004 Sep; 24(3):199-207. PubMed ID: 15300847 [TBL] [Abstract][Full Text] [Related]
20. 12 year follow up of enzyme-replacement therapy in two siblings with attenuated mucopolysaccharidosis I: the important role of early treatment. Gabrielli O; Clarke LA; Ficcadenti A; Santoro L; Zampini L; Volpi N; Coppa GV BMC Med Genet; 2016 Mar; 17():19. PubMed ID: 26965916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]